- Home
- TNXP vs TYGO Comparison
TNXP vs TYGO Comparison
Compare TNXP & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- TYGO
- Stock Information
- Founded
- TNXP 2007
- TYGO 2007
- Country
- TNXP United States
- TYGO United States
- Employees
- TNXP N/A
- TYGO N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- TYGO Semiconductors
- Sector
- TNXP Health Care
- TYGO Technology
- Exchange
- TNXP Nasdaq
- TYGO Nasdaq
- Market Cap
- TNXP 71.6M
- TYGO 63.2M
- IPO Year
- TNXP N/A
- TYGO N/A
- Fundamental
- Price
- TNXP $18.18
- TYGO $0.85
- Analyst Decision
- TNXP Strong Buy
- TYGO Buy
- Analyst Count
- TNXP 2
- TYGO 3
- Target Price
- TNXP $585.00
- TYGO $3.00
- AVG Volume (30 Days)
- TNXP 2.6M
- TYGO 16.5K
- Earning Date
- TNXP 03-18-2025
- TYGO 05-13-2025
- Dividend Yield
- TNXP N/A
- TYGO N/A
- EPS Growth
- TNXP N/A
- TYGO N/A
- EPS
- TNXP N/A
- TYGO N/A
- Revenue
- TNXP $10,094,000.00
- TYGO $54,014,000.00
- Revenue This Year
- TNXP $84.08
- TYGO $61.65
- Revenue Next Year
- TNXP $126.94
- TYGO $28.03
- P/E Ratio
- TNXP N/A
- TYGO N/A
- Revenue Growth
- TNXP 29.94
- TYGO N/A
- 52 Week Low
- TNXP $6.76
- TYGO $0.76
- 52 Week High
- TNXP $672.00
- TYGO $1.85
- Technical
- Relative Strength Index (RSI)
- TNXP 48.95
- TYGO 41.50
- Support Level
- TNXP $12.80
- TYGO $0.85
- Resistance Level
- TNXP $31.87
- TYGO $1.03
- Average True Range (ATR)
- TNXP 4.30
- TYGO 0.07
- MACD
- TNXP 0.57
- TYGO -0.00
- Stochastic Oscillator
- TNXP 22.53
- TYGO 5.26
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About TYGO Tigo Energy Inc.
Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems.